The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: 10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)
Official Title: 10-year CHD Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer Patients Taking Aromatase Inhibitors
Study ID: NCT00885612
Brief Summary: 10-year CHD risk evaluation and its treatment pattern analysis in postmenopausal early breast cancer patients taking aromatase inhibitors.
Detailed Description:
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Research Site, Cheonan, Chungcheongnam-do, Korea, Republic of
Research Site, Chuncheon, Gangwon-do, Korea, Republic of
Research Site, Goyang-si, Gyeonggi-do, Korea, Republic of
Research Site, Seongnam-si, Gyeonggi-do, Korea, Republic of
Research Site, Pohang, Gyeongsangbuk-do, Korea, Republic of
Research Site, Masan-si, Gyeongsangnam-do, Korea, Republic of
Research Site, Anyang, , Korea, Republic of
Research Site, Busan, , Korea, Republic of
Research Site, Chunan, , Korea, Republic of
Research Site, DaeGu, , Korea, Republic of
Research Site, Daejeon, , Korea, Republic of
Research Site, Daejon, , Korea, Republic of
Research Site, GuangJu, , Korea, Republic of
Research Site, Gwangju, , Korea, Republic of
Research Site, Incheon, , Korea, Republic of
Research Site, Inchon, , Korea, Republic of
Research Site, Jeonju, , Korea, Republic of
Research Site, Kangnung, , Korea, Republic of
Research Site, Koyang, , Korea, Republic of
Research Site, Kyunggi, , Korea, Republic of
Research Site, Pusan, , Korea, Republic of
Research Site, Seoul(Kangbuk), , Korea, Republic of
Research Site, Seoul(Kangdong), , Korea, Republic of
Research Site, Seoul(Kangnam), , Korea, Republic of
Research Site, Seoul(Yeouido), , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Suwon, , Korea, Republic of
Research Site, Ulsan, , Korea, Republic of
Name: JoonWoo Bahn, MD, PhD
Affiliation: AstraZeneca Korea
Role: STUDY_DIRECTOR